FDA Warning Letters relating to Computerised Systems
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Significant violations of GMP are published by the US FDA in Warning Letters. The GMP complaints always refer to the relevant section of the American GMP rules CFR 21 Part 211 - Current Good Manufacturing Practice For Finished Pharmaceuticals. Actually, parts of two Warning Letters address in detail problems in connection with computerised systems. The point of reference 211.68 deals with "Automatic, mechanical, and electronic equipment".
1. Compania Internacional de Comercio, S.A. de C.V. under point 5:
Your firm has not established and documented the accuracy, reliability and performance of your computer systems employed in the release of drug products [21 C.F.R. 211.68 (a)]
2, Shamrock Medical Solutions Group LLC under point 1:
Your firm has failed to exercise appropriate controls over computer or related systems to assure that changes in master production and control records, or other records, are instituted only by authorized personnel [21 C.F.R § 211.68(b)].
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
02.09.2026Cloud Computing: Authorities' Expectations od Cloud Service Providers?
26.08.2026Cloud Computing: IT Infrastructure Qualification by a SAAS Provider
19.08.2026Cloud Computing: How can CSPs Achieve the Annex 11 Requirement of Qualified Infrastructure?
30.07.2025Annex 11 Draft - First Analysis
09.07.2025Drafts of EU GMP Guideline Annex 11, Annex 22 and Chapter 4 released for comment